Cerus
CERS
$1.62
Share price
3.18%
Change (1 day)
-72.21%
Change (1 year)
Categories
Revenue for Cerus (CERS)
Revenue in 2023 (TTM): $0.15 B
According to Cerus's latest financial reports the company's current revenue (TTM) is $0.15 B. In 2022 the company made a revenue of $0.16 B an increase over the years 2021 revenue that were of $0.13 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Cerus from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.15 B | -5.32% |
| 2022 | $0.16 B | 23.83% |
| 2021 | $0.13 B | 42.36% |
| 2020 | $91.92 M | 23.14% |
| 2019 | $74.64 M | 22.56% |
| 2018 | $60.9 M | 39.8% |
| 2017 | $43.56 M | 17.17% |
| 2016 | $37.18 M | 8.65% |
| 2015 | $34.22 M | -6.25% |
| 2014 | $36.5 M | -7.95% |
| 2013 | $39.65 M | 7.8% |
| 2012 | $36.78 M | 11.32% |
| 2011 | $33.04 M | 42.99% |
| 2010 | $23.1 M | 28.51% |
| 2009 | $17.98 M | 8.94% |
| 2008 | $16.5 M | 49.47% |
| 2007 | $11.04 M | -68.96% |
| 2006 | $35.58 M | 45.99% |
| 2005 | $24.37 M | 75.19% |
| 2004 | $13.91 M | 43.93% |
| 2003 | $9.66 M | 13.84% |
| 2002 | $8.49 M | 87.21% |
| 2001 | $4.53 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | $13.40 B | 8,633.51% | 🇺🇸 USA |
 Utah Medical Products UTMD | $51.91 M | -66.16% | 🇺🇸 USA |
 Haemonetics HAE | $1.21 B | 694.19% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | N/A | N/A | 🇺🇸 USA |